Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing ...

Replimune's innovative cancer therapies, strong cash reserves, and FDA support position it to disrupt oncology markets. Click ...

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.